Congenital heart disease (CHD) is the most common birth defect, occurring in up to 1% of live births ([@B1]). Interestingly, CHD often presents in combination with extra cardiac defects including congenital anomalies of the kidney and urinary tract (CAKUT) ([@B2]--[@B4]). In fact, renal or urinary system defects are associated with 23.1% of congenital heart defects ([@B5]). These findings suggest an overlapping genetic etiology for CHD and CAKUT. Consistent with this is the fact that several previously reported mouse models (not individually discussed in this review) have found genetic disruption of a single gene can affect both heart and kidney development, and that many genetic syndromes can present with both cardiac and renal anomalies ([@B6]--[@B9]). Hence, insights into the genetic etiology of CHD may help elucidate the etiology of CAKUT. Relevant to this is the recent unexpected finding from a large-scale forward genetic screen in mice indicating a significant role for cilia-related mutations in the pathogenesis of CHD ([@B10]). As cilia mutations are well-described in the context of CAKUT, this would suggest cilia defects may have a central role in mediating both CHD and CAKUT phenotypes. Below, we briefly discuss CAKUT and its association with CHD, and its shared genetic etiology involving cilia-related mutations.

Association of heart and kidney phenotypes in genetic syndromes {#s1}
===============================================================

CAKUT represent a broad range of kidney and urinary tract defects. This can include abnormalities in the shape, size, or structure of the kidney including kidney agenesis, kidney hypoplasia or dysplasia, horseshoe/fused kidney, cystic kidneys, or duplex/multiplex kidney, and multiple collecting ducts or ureters ([@B11]). These defects can occur in combination such as with the finding of cystic dysplastic kidneys. These structural abnormalities can result in vesicoureteral reflux, ureteropelvic junction obstruction, hydroureter, and hydronephrosis ([@B10], [@B12]). In humans, monogenic mutations in several genes have been implicated in CAKUT development; however, these mutations explain only 5--20% of patient disease ([@B13]). Additional causes of CAKUT phenotypes include genetic syndromes, which can present with a spectrum of phenotypes often involving defects in many organs including both the heart and the kidney.

In DiGeorge syndrome, heterozygous deletion of chromosome 22q11.2 is associated with multiple organ defects, including the heart, the kidney, the thymus, and the nervous system. It has an estimated prevalence of 1:3,000 to 1:4,000 live births, though prenatal chromosomal analysis suggests this may be an underestimate, and affected patients characteristically present with CHD, thymus hypoplasia or agenesis, and craniofacial defects ([@B14]--[@B16]). Approximately 20--30% of DiGeorge syndrome patients also exhibit CAKUT ([@B17]). Haploinsufficiency of *TBX1*, a transcription factor within the T-box family, has been shown to contribute to the cardiac phenotypes associated with this disorder ([@B18], [@B19]). More recently, another gene within the 22q11.2 locus, *CRKL*, an adaptor protein that regulates tyrosine kinase signaling, was found to contribute to developmental kidney defects in the context of DiGeorge syndrome ([@B20], [@B21]).

Another syndrome known as VACTERL association also presents with both congenital heart defects and renal abnormalities. Occurring in 1:10,000 to 1:40,000 live births, VACTERL association is a birth defect associated with at least 3 of the following phenotypes: vertebral defects, anal atresia, cardiac defects, trachea-esophageal fistula, renal defects, and limb defects ([@B22]). In a large study of patients diagnosed with VACTERL association, 80% exhibited kidney defects and 48% exhibited cardiac defects ([@B23]). In humans, several genes have been related to VACTERL association including *FGF8, FOXF1, HOXD13, LPP, TRAP1, and ZIC3*, all of which have been implicated in kidney developmental anomalies, with ZIC3 being an X-linked gene also shown to cause heterotaxy ([@B24]).

A rarer genetic disorder known as Fraser syndrome can also cause both CHD and genitourinary abnormalities. It is a recessive disorder with a prevalence of only 1 in 200,000 ([@B25]). Patients with Fraser syndrome can present with eye defects, syndactyly, kidney defects, most commonly kidney agenesis, and heart defects ([@B25]). Fraser syndrome is associated with mutations in *FRAS1, FREM2*, or *GRIP1*, all of which are known to interact to form a FRAS/FREM complex that is localized to the basement membrane ([@B26], [@B27]). Mutations in these genes cause loss of the FRAS/FREM complex that likely drives the disease phenotypes observed in Fraser syndrome, although the precise disease mechanism remains unclear ([@B27], [@B28]).

Cilia and the genetic landscape of CHD {#s2}
======================================

The close association of renal anomalies with CHD suggests insights into the genetics of CHD can yield significant insights into the mechanism of disease pathogenesis for CAKUT. Interestingly, the pursuit of a large-scale forward genetic screen in mice for mutations causing CHD yielded a large preponderance of mutations in cilia-related genes ([@B29]). From screening more than 100,000 ethylnitrosourea (ENU) mutagenized mice using *in utero* fetal ultrasound phenotyping, we recovered over 200 mouse lines with a wide spectrum of CHD. Using whole exome sequencing nearly 100 CHD-causing mutations were recovered in 61 genes, 34 (55.7%) of which were cilia-related ([@B29]). As this is a phenotype driven mutagenesis screen in which fetal echocardiography was used to identify mutants with CHD, these findings point to cilia as playing a central role in the pathogenesis of CHD. This is corroborated with the completion of the screen, showing over 50 genes are cilia-related among 100 genes recovered causing CHD. Moreover, analysis of de novo mutations identified in whole exome sequencing analysis from CHD patients also identified similar mutations contributing to CHD pathogenesis ([@B30]).

Cilia and ciliopathies in CHD, renal anomalies, and other human diseases {#s3}
========================================================================

Cilia are microtubule-based organelles that have well-described compartments including an axoneme that projects from the apical cell surface, and a basal body base with an overlying transition zone and inversin compartment that regulate protein trafficking into and out of the cilium (Figure [1](#F1){ref-type="fig"}) ([@B32]). Cilia can be motile with the expression of motor dyneins that drive ciliary motility, or nonmotile, termed primary cilia, which extend from almost all cell types in the body, including cells of the developing heart, and are known to serve important cell signaling functions by mediating various signal transduction processes ([@B33]--[@B35]). Motile cilia are required for left-right patterning as well as in mediating sperm motility, mucociliary clearance in the airway, and also cerebral spinal fluid flow in the brain. Importantly, it is now appreciated that cilia mutations can cause a wide spectrum of human diseases collectively known as ciliopathies ([@B31]). Many of these ciliopathies can present with renal anomalies, such as in nephronepthesis, Meckel-Gruber syndrome (MKS), Bardet-Biedl syndrome (BBS), Joubert syndrome, Alstrom syndrome and polycystic kidney disease among others ([@B36]). The renal defects observed may include CAKUT, polycystic kidney disease or progressive renal dysfunction. Other structural birth defects observed in the ciliopathies include CHD, cardiomyopathy, skeletal malformations, brain abnormalities, blindness, and obesity ([@B31]).

![Ciliary localization of proteins that when mutated cause congenital heart disease recovered from a large-scale screen. Mutations in several of these proteins can also cause CAKUT. Adapted from Damerla et al. ([@B31]).](fped-06-00175-g0001){#F1}

Many of the mutations known to cause renal anomalies within the ciliopathy spectrum are associated with proteins localized in the cilia transition zone or inversin compartment. Thus, among the 61 genes recovered causing CHD, half (*N* = 34) were cilia-related, including 11 affecting transition zone or inversin compartment components ([@B29]). While these are mainly thought to disrupt primary cilia function, recent studies showed ciliopathies generally considered to involve primary cilia defects may also impact motile cilia function. This is indicated by the observation of airway clearance defects in patients diagnosed with ciliopathies such as Leber congenital amaurosis or Sensenbrenner syndrome ([@B37], [@B38]). This is not unexpected given over 70% of proteins required for primary cilia function are also expressed in motile cilia ([@B39]). Indeed, airway clearance defects are the hallmark of a ciliopathy known as primary ciliary dyskinesia (PCD).

PCD patients have severe sinopulmonary disease and typically this is associated with mutations in genes required for motile cilia function, such as motor dyneins ([@B40]--[@B42]). It is interesting to note some isolated reports of bronchiectasis associated with polycystic kidney disease, although the connection with airway clearance defects is unknown ([@B43]). PCD patients also can exhibit laterality defects, a reflection of the requirement for motile cilia in the specification of the left-right body axis ([@B44], [@B45]). Consistent with this, PCD patients can display a spectrum of phenotypes including situs solitus (normal visceral organ situs), situs inversus totalis also known as Kartagener\'s syndrome (reversed visceral organ situs), and heterotaxy, or the randomization of visceral organ situs. In this context, CHD is often associated with heterotaxy as a result of defects in motile cilia function.

Interestingly, some ciliopathies thought to affect only primary cilia function also can be associated with laterality defects, one prominent example being MKS, a ciliopathy that causes severe birth defects and is usually prenatal or neonatal lethal. Studies of *Mks1* mutant mice showed defects involving not only the primary cilia, but also laterality defects associated with the loss of motile cilia function in the embryonic node ([@B46]). Together, these findings suggest that the distinction of ciliopathies as either affecting motile or primary cilia can be problematic, given the promiscuity of cilia genes in having functional roles in both primary and motile cilia.

Intriguingly, primary cilia proteins can be found in other cellular locations, suggesting that they may have other non-ciliary functions ([@B47]). In fact, ciliary proteins are also involved in a wide range of cellular processes including cell cycle progression, cytoskeletal organization, and vesicular trafficking ([@B48]--[@B50]). Further, cilia themselves are involved in several cell signaling pathways including the sonic hedgehog, TGFβ, wnt, and notch pathways, and defects can arise in these pathways through defective cilia or pathway components outside of the cilium ([@B51]). Thus, future research will be important to determine the precise roles cilia and cilia associated proteins play in CHD and CAKUT development.

Mutations causing CHD and CAKUT phenotypes {#s4}
==========================================

Extra-cardiac phenotypes, including renal anomalies, were recovered in many CHD mutant mice even though the screen was entirely focused on CHD phenotyping. This included a spectrum of kidney phenotypes including duplex kidney, multiplex kidney, hydronephrosis, kidney agenesis, and cystic kidney (Figure [2](#F2){ref-type="fig"}), with the most commonly observed renal phenotype being duplex kidneys ([@B10]). Among the 39 mutant mouse lines recovered with congenital kidney abnormalities, the most common CHD phenotype is double outlet right ventricle (DORV), occurring in 19/39 lines (48.7%). This is followed by atrioventricular septal defect, which occurred in 15/39 lines (38.5%; Table [1](#T1){ref-type="table"}). Other CHD phenotypes associated with kidney defects included transposition of the great arteries (TGA), persistent truncus arteriosus (PTA), ventricular septal defect (VSD), aortic arch anomalies, and biventricular hypertrophy (Table [1](#T1){ref-type="table"}).

![Kidney Phenotypes Observed in Mice with Congenital Heart Disease. Representative examples of the kidney phenotypes observed in mice with congenital heart disease recovered from a large scale forward genetic screen. Phenotypes can be observed at necropsy and upon H&E staining. Adapted from San Agustin et al. ([@B10]). Control necropsy **(Aa)** and control H&E stained kidneys **(Ab)** can be compared with mutant necropsy **(Ba,Ca,Da,Ea,F,G)** and mutant H&E stained kidneys **(Bb,Cb,Db,Eb, H--J)**. ^\*^represents hydronephrosis.](fped-06-00175-g0002){#F2}

###### 

Renal anomalies associated with genes causing congenital heart defects.

  **Gene[^a^](#TN1){ref-type="table-fn"}**              **Duplex/multiplex**   **Hydro-nephrosis**   **Cystic**   **Agenesis/Hypoplasia**   **Cardiac phenotype**
  ----------------------------------------------------- ---------------------- --------------------- ------------ ------------------------- ----------------------------------------------------------
  ***Anks6*[^\*^](#TN2){ref-type="table-fn"} (10)**     --                     --                    80%          --                        DORV, TGA, AVSD, VSD
  ***Bicc1*[^\*^](#TN2){ref-type="table-fn"} (8)**      --                     --                    100%         --                        DORV, TGA, AVSD, IAA
  ***Cc2d2a*[^\*^](#TN2){ref-type="table-fn"} (5)**     --                     --                    100%         --                        TGA, PTA, DORV, AVSD, Pulmonary Atresia
  ***Cep110* (5)**                                      --                     60%                   --           --                        DORV, AVSD, VSD
  ***Cep290*[^\*^](#TN2){ref-type="table-fn"} (13)**    15%                    --                    100%         --                        DORV, AVSD
  ***Dync2h1*[^\*^](#TN2){ref-type="table-fn"} (6)**    50%                    --                    --           --                        PTA/Pulmonary atresia, VSD, MAPCA
  ***Lrp2* (3)**                                        --                     100%                  100%         --                        PTA, VSD, Ao arch defects
  ***Pkd1*** **(4)**                                    --                     --                    100%         --                        Biventricular Hypertrophy
  ***Ptk7*** **(3)**                                    --                     --                    100%         --                        DORV, VSD, Biventricular Hypertrophy
  ***Tbc1d32*[^\*^](#TN2){ref-type="table-fn"} (12)**   25%                    --                    92%          --                        PTA, DORV, TGA, AVSD
  ***Tmem67*[^\*^](#TN2){ref-type="table-fn"} (12)**    42%                    --                    100%         --                        DORV, AVSD, IAA
  *Adamts6* (16)                                        --                     56%                   --           --                        DORV, OA
  *Ap1b1*[^\*^](#TN2){ref-type="table-fn"} (10)         --                     --                    80%          --                        AVSD, VSD, Atrial Isomerism
  *Ap2b1* (3)                                           --                     --                    75%          --                        DORV/Taussig-Bing, AVSD, VSD, Ao arch defects
  *Bmp10* (2)                                           --                     --                    100%         --                        DORV
  *Cxcr4* (5)                                           60%                    --                    --           --                        VSD, Ao atresia, Ao arch defects
  *Frem2* (10)                                          --                     --                    --           100%                      Biventricular Hypertrophy
  *Lama5* (5)                                           --                     --                    --           60%                       DORV
  *Plxnd1* (3)                                          --                     --                    --           63%                       PTA, DORV, AVSD, RAA
  *Prdm1* (8)                                           38%                    --                    --           --                        DORV, AVSD, VSD, Ao atresia, Ao arch defects
  *Qrich1* (3)                                          --                     --                    --           67%                       DORV, AVSD, noncompaction
  *Robo1* (5)                                           100% (M)               --                    --           --                        VSD, Biventricular Hypertrophy
  *Slit2* (7)                                           100% (M)               --                    --           --                        DORV, VSD, Ao arch defects
  *Snx17* (3)                                           66%                    --                    --           --                        DORV/OA, AVSD
  *Wnt5a* (7)                                           43%                    --                    --           --                        DORV, PTA, AVSD, VSD
  *Zbtb14* (4)                                          --                     --                    100%         --                        DORV, AVSD, atrioventricular and semilunar valve defects

*Gene with dark highlighting are ciliary components based on proteomic and other studies*.

Gene names followed by

*indicate mutations that cause situs defects*.

*Parenthesis indicate the number of mutants analyzed*.

*Adapted from San Agustin et al. ([@B10])*.

Previous attempts to recover CAKUT genes have been confounded by incomplete penetrance and the probable involvement of more complex genetics. The few CAKUT genes previously identified are largely those that mediate the early steps in kidney development and patterning. Other than *Pax2*, which causes renal coloboma syndrome, and *Hnf1b*, which causes renal cystic disease and diabetes, most genes identified to cause CAKUT are associated with disease in only a few patients and hence, the evidence supporting pathogenesis is limited ([@B52]). Among the 135 CHD mouse lines recovered, 39 (28.8%) had kidney defects caused by mutations in 26 genes, 11 (42%) being known cilia genes (Table [1](#T1){ref-type="table"}, Figure [1](#F1){ref-type="fig"}) ([@B10]). Remarkably, this included four cilia genes that encoded known direct protein-protein interactors: *Anks6, Nek8, Bicc1*, and *Wwtr1* ([@B53]--[@B56]). These mutations were found in four independent CHD mouse lines, with mutation in each gene causing a similar spectrum of kidney and heart defect phenotypes comprising double outlet right ventricle and cystic kidney disease (Figure [3](#F3){ref-type="fig"}).

![Mutations in interacting proteins cause a similar spectrum of both heart and kidney phenotypes. Mutations in four interacting proteins, *Anks6, Bicc1, Nek8*, and *Wwtr1* cause similar phenotypes including both congenital heart disease and cystic kidney disease (Unpublished data).](fped-06-00175-g0003){#F3}

Clinical study showing association of CHD with CAKUT phenotypes {#s5}
===============================================================

The relevance of CAKUT abnormalities in CHD was confirmed with a clinical study of 77 CHD patients recruited from the Children\'s Hospital of Pittsburgh. Retrospective review of the medical records of these 77 patients revealed 23 (30%) also had some form of renal defect such as renal cysts, kidney agenesis, cystic dysplastic kidneys, and horseshoe kidney (Figure [4](#F4){ref-type="fig"}, Table [2](#T2){ref-type="table"}) ([@B10]). These findings are in agreement with a previous epidemiological study in the Atlanta metro area, which showed 23% of 8,000 subjects with CHD also had renal abnormalities ([@B1]). Thus, both the mouse and human studies point to a significant overlap in the genetic etiology of CHD and kidney abnormalities. This probably reflects the conservation of developmental pathways and cell signaling mechanisms that regulate cardiovascular and renal development, including a central role for cilia in the pathogenesis of CHD and renal birth defects. Together these findings suggest the routine evaluation of CHD patients for renal anomalies with simple non-invasive renal ultrasound may be warranted. This may allow early diagnosis and early therapeutic intervention to treat and manage any renal dysfunction that could negatively impact the long-term outcome of this high-risk patient population.

![Kidney Defects Observed in Patients with CHD. Renal ultrasound of patients with congenital heart disease unveils a spectrum of renal abnormalities including intrarenal collecting system dilation **(A--C)**, cystic-dysplastic abnormalities **(D--F)**, horseshoe kidney **(G)**, and duplicated collecting system depicted with renal ultrasound **(H)**, and voiding cystourethrogram **(I)**. Adapted from San Agustin et al. ([@B10]).](fped-06-00175-g0004){#F4}

###### 

Clinical characteristics of congenital heart disease patients.

  **ID \#**   **Kidney phenotypes**                                     **Cardiac phenotype[^\*^](#TN3){ref-type="table-fn"}**   **Other phenotypes**
  ----------- --------------------------------------------------------- -------------------------------------------------------- ----------------------------------------------
  7042        Abnormally rotated kidney, Pelvicaliectasis               HLHS                                                     
  7199        Caliectasis (dilation of the renal calices)               HLHS                                                     Hypothyroidism
  7351        Duplicated collecting duct system, Hydronephrosis         HLHS                                                     
  7208        Duplicated collecting system, Vesicoureteral reflux       D-TGA                                                    
  7319        Ectopic kidney                                            DORV, subaortic VSD                                      
  7040        Ectopic kidney, vesicoureteral reflux                     ASD, VSD                                                 
  7194        Horseshoe kidney                                          TOF, PA                                                  
  7035        Hydronephrosis                                            ASD, VSD                                                 Tethered cord, hypothyroidism
  7288        Mild Hydronephrosis                                       Truncus arteriosus                                       
  7053        Pelvicaliectasis                                          D-TGA                                                    
  7302        Pelvicaliectasis                                          HLHS                                                     
  7306        Pelvicaliectasis                                          D-TGA                                                    
  7334        Pelvicaliectasis                                          ASD, VSD, PDA, Interrupted IVC                           
  7389        Pelvicaliectasis                                          HLHS                                                     
  7417        Pelvicaliectasis                                          VSD/PDA/ventricular hypertrophy                          
  7419        Pelvicaliectasis                                          DORV, PA, complete AVSD, supracardiac TAPVR              Heterotaxy, asplenia
  7430        Pelvicaliectasis                                          Unbalanced AVSD, PA, supracardiac TAPVR                  Heterotaxy, asplenia
  7058        Pelvicaliectasis, Hydroureter                             TOF                                                      Tethered cord, exotropia, neurogenic bladder
  7336        Pyelectasis (dilation of the renal pelvis)                D-TGA                                                    
  7289        Renal size asymmetry, Solitary cyst seen by ultrasound.   HLHS                                                     
  7474        Unilateral Agenesis                                       HLHS                                                     Single testis
  7027        Vesicoureteral reflux                                     D-TGA                                                    Situs inversus totalis, seizures
  7438        Vesicoureteral reflux                                     HLHS                                                     Aspiration, hypospadias

*D-TGA, D-transposition of the great arteries; DORV, double outlet right ventricle; ASD, atrial septal defect; VSD, ventricular septal defect; HLHS, hypoplastic left heart syndrome; TOF, Tetralogy of Fallot; AVSD, atrioventricular septal defect; PA, pulmonary atresia; TAPVR, total anomalous pulmonary venous return. Adapted from San Agustin et al. ([@B10])*.

Conclusion {#s6}
==========

Studies in both CHD mutant mice and CHD patients showed CAKUT is highly associated with CHD. This is supported by the finding of CAKUT and CHD in various genetic syndromes, and the finding that many mutations identified to cause CHD can also cause CAKUT phenotypes. Among genes identified to cause both CHD and CAKUT there is a significant enrichment of cilia genes, indicating a central role for cilia in the pathogenesis of CHD and CAKUT phenotypes. However, as half of the mutations identified to cause CHD and renal anomalies are not known to be cilia-related, the association of CHD with renal anomalies likely extend beyond the role of cilia in heart and kidney development. The clinical relevance of these findings in mice were shown with the observation that 23--30% of CHD patients also exhibited renal anomalies. This would suggest CHD patients may benefit from routine evaluation for renal anomalies. This might improve the long-term outcome of this high-risk patient population by reducing potential renal complications with early diagnosis and therapeutic intervention.
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